SCHEMBL25868838

SCHEMBL25868838

BC(B)(F)Oc1ccc(-c2ccc3oc(=O)n(CCCN4CCOC4=O)c3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 2/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SCN1A P35498 1/20 0.37
SCN4A P35499 1/20 0.37
KCNH2 Q12809 1/20 0.37
SCN5A Q14524 1/20 0.37
SCN9A Q15858 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
SCN8A Q9UQD0 1/20 0.37
SCN10A Q9Y5Y9 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22314552 0.93 SCN1A (0.43) TMEM97TP53MAPTSMN1; SMN2THRB
SCHEMBL25868000 0.81 KMO (0.44) TP53MAPTSMN1; SMN2ALDH1A1TSPO
SCHEMBL22314551 0.78 TMEM97 (0.42) TMEM97TP53MAPTSMN1; SMN2THRB
SCHEMBL25868162 0.74 SMN1; SMN2 (0.44) TP53MAPTSMN1; SMN2THRBTDP1
SCHEMBL25865015 0.74 TP53 (0.47) TP53MAPTSMN1; SMN2THRBTDP1
SCHEMBL22314500 0.74 TP53 (0.44) TP53MAPTSMN1; SMN2THRBTDP1
SCHEMBL22314498 0.73 MAPT (0.53) TP53MAPTSMN1; SMN2THRBTDP1
SCHEMBL22314474 0.72 KMO (0.46) TP53MAPTSMN1; SMN2ALDH1A1TSPO
SCHEMBL25865022 0.72 ALDH1A1 (0.46) TP53MAPTSMN1; SMN2THRBTDP1
SCHEMBL22314478 0.72 ALDH1A1 (0.41) TP53MAPTSMN1; SMN2THRBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PREC MEDICINES INC (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B TMEM97 959/4885TP53 4487/4885MAPT 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.